Incidence and risk factors of deep vein thrombosis after extracorporeal life support

Olivier van Minnen, Walter M. van den Bergh, Joep M. Droogh, Lisette Koehorst, Wim K. Lagrand, S. Jorinde Raasveld, Annemieke Oude Lansink-Hartgring, Aart Terpstra, Jasper M. Smit, Pieter R. Tuinman, Alexander P. J. Vlaar

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)

Abstract

Background: Deep vein thrombosis (DVT) after decannulation of extracorporeal life support (ECLS) is not uncommon. Moreover, the impact of anticoagulation and potential risk factors is unclear. Furthermore, it is unclear if cannula-associated DVT is more common in ECLS patients compared to critically ill patients without ECLS. Methods: All adult patients who were successfully weaned from ECLS and were screened for DVT following decannulation were included in this observational cohort study. The incidence of post-ECLS-DVT was assessed and the cannula-associated DVT rate was compared with that of patients without ECLS after central venous catheter (CVC) removal. The correlation between the level of anticoagulation, risk factors, and post-ECLS-DVT was determined. Results: We included 30 ECLS patients and 53 non-ECLS patients. DVT was found in 15 patients (50%) of which 10 patients had a DVT in a cannulated vein. No correlation between the level of anticoagulation and DVT was found. V-V ECLS mode was the only independent risk factor for post-ECLS-DVT (OR 5.5; 95%CI 1.16–26.41). We found no difference between the ECLS and non-ECLS cohorts regarding cannula-associated DVT rate (33% vs. 32%). Conclusion: Post-ECLS-DVT is a common finding that occurs in half of all patients supported with ECLS. The incidence of cannula-associated DVT was equal to CVC-associated DVT in critically ill patients without ECLS. V-V ECLS was an independent risk factor for post-ECLS-DVT.
Original languageEnglish
Pages (from-to)1893-1900
Number of pages8
JournalArtificial organs
Volume46
Issue number9
Early online date24 Apr 2022
DOIs
Publication statusPublished - Sept 2022

Keywords

  • anticoagulant
  • deep vein thrombosis
  • extracorporeal life support

Cite this